Chevallard Daniel R. - Insider Non-Derivative Transactions at Viracta Therapeutics, Inc. (VIRX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 27, 2024, Chevallard Daniel R.'s relationship to Viracta Therapeutics, Inc. (VIRX) is Officer (CFO and COO), and currently has 102,306 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other VIRX insiders.

Data Source: SEC.
Chevallard Daniel R. - Insider Non-Derivative Transactions of VIRX Common Stock
Chevallard Daniel R. - Insider Non-Derivative Transactions at VIRX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 28, 2024 Sell -- (Common Stock) 3405 0.73 102306
Feb 26, 2024 M -- (Common Stock) 6889 0 105711
Nov 29, 2023 Sell -- (Common Stock) 3720 0.5 98822
Nov 26, 2023 M -- (Common Stock) 6889 0 102542
Aug 29, 2023 Sell -- (Common Stock) 3512 1.45 95653
Aug 26, 2023 M -- (Common Stock) 6888 0 99165
May 26, 2023 Sell -- (Common Stock) 3635 1.42 92277
May 26, 2023 M -- (Common Stock) 6889 0 95912
Feb 28, 2023 Sell -- (Common Stock) 3599 1.68 89023
Feb 26, 2023 M -- (Common Stock) 6889 0 92622